Arthritis, Rheumatoid: all 2,962 studies

Page 10 of 30. Open to participants first (396), then studies with results posted, then the rest; newest registration first within each.

• Efficacy and Safety Study of MP-435 in Combination With Methotrexate (MTX) in Patients With Rheumatoid ArthritisCompletedNCT01143337Phase 2Results posted
• Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid ArthritisCompletedNCT01142726Phase 3Results posted
• Hydroxychloroquine to Improve Insulin Sensitivity in Rheumatoid ArthritisCompletedNCT01132118Phase 3Results posted
• SMART Study: A Study of Re-treatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNF Alfa TherapyCompletedNCT01126541Phase 3Results posted
• Phase 1 Trial of Type II Collagen (CII) APL A12 in Rheumatoid Arthritis PatientsCompletedNCT01123655Phase 1Results posted
• TL011 in Severe, Active Rheumatoid Arthritis PatientsCompletedNCT01123070Phase 1Results posted
• A Study of Tocilizumab (RoActemra/Actemra) Versus Adalimumab in Patients With Rheumatoid ArthritisCompletedNCT01119859Phase 4Results posted
• Real Life Evaluation of Rheumatoid Arthritis in Canadians Taking HUMIRACompletedNCT01117480Results posted
• Iyengar Yoga for Young People With Rheumatoid ArthritisCompletedNCT01096823Not applicableResults posted
• A Study of Tocilizumab as Monotherapy or in Combination With DMARDs in Patients With Moderate to Severe Active Rheumatoid ArthritisCompletedNCT01089023Phase 4Results posted
• A 3-year Study Following up Patients With Moderate to Severe Rheumatoid Arthritis Treated With Humira in GreeceCompletedNCT01086033Results posted
• Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS) After Unsustainable Response to Biologicals and Disease Modifying Antirheumatic DrugsCompletedNCT01083693Results posted
• Clinical Outcomes, Compliance and Effectiveness of Switching From Infliximab or Etanercept to Adalimumab in Patients With Active Rheumatoid Arthritis (RA). A Multicenter Post-Marketing Observational Study in Routine Clinical UseTerminatedNCT01083160Results posted
• Safety and Effectiveness of Adalimumab in Patients Diagnosed With Rheumatoid ArthritisCompletedNCT01078571Results posted
• A Belgian Registry of HUMIRA® (Adalimumab) in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis ( ProAct )CompletedNCT01078558Results posted
• EValuation of HumIRA® in Patients With Active Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in EASTern European CountriesCompletedNCT01078402Results posted
• Evaluation of the Role of Adalimumab on Extraarticular Manifestation - Bone Metabolism and Bone Mineral Density in Patients With Active Rheumatoid ArthritisCompletedNCT01078155Results posted
• Cost Utility Analyses of Adalimumab Treatment in Patients With Rheumatoid Arthritis (RA)CompletedNCT01078116Results posted
• Effectiveness and Safety of Adalimumab in Rheumatoid Arthritis Patients in Routine Clinical PracticeCompletedNCT01078090Results posted
• Efficacy and Safety of Adalimumab in Patients With Rheumatoid Arthritis in Routine Clinical PracticeCompletedNCT01077258Results posted
• Drug Use Investigation for Humira® - All Patient Investigation for Rheumatoid ArthritisCompletedNCT01076959Results posted
• Safety and Effect on Quality of Life/Work Productivity of Humira in Patients With Rheumatoid ArthritisCompletedNCT01076205Results posted
• An Observational Study on the Safety and Effectiveness of Rituximab in Patients With Severe Active Rheumatoid ArthritisCompletedNCT01071798Results posted
• Observation of Treatment With Certolizumab Pegol in Daily PracticeCompletedNCT01069419Results posted
• A Study With Tocilizumab [RoActemra/Actemra] Monotherapy or in Combination With Methotrexate in Patients With Rheumatoid Arthritis (PICTURE)CompletedNCT01063062Phase 3Results posted
• Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis PatientsCompletedNCT01061736Phase 2/3Results posted
• T Cells and TNF (Tumor Necrosis Factor): The Impact of TNF BlockadeCompletedNCT01060098Results posted
• Study Of The Effects Of Atorvastatin On Cholesterol Levels In Rheumatoid Arthritis Patients Taking CP-690,550CompletedNCT01059864Phase 2Results posted
• Safety and Efficacy of AMG 827 in Subjects With RATerminatedNCT01059448Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of CAM-3001 (Drug) in Subjects With Rheumatoid ArthritisCompletedNCT01050998Phase 2Results posted
• A Study of Tocilizumab in Combination With an Oral Contraceptive in Patients With Rheumatoid ArthritisCompletedNCT01044498Phase 3Results posted
• Comparing The Effectiveness And Safety Of 2 Doses Of An Experimental Drug, CP-690,550, To Methotrexate (MTX) In Patients With Rheumatoid Arthritis Who Have Not Previously Received MTXCompletedNCT01039688Phase 3Results posted
• A Study of Tocilizumab Plus Non-biological DMARD in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Non-biological DMARDsCompletedNCT01034397Phase 4Results posted
• Oral CF101 Tablets Treatment in Patients With Rheumatoid ArthritisCompletedNCT01034306Phase 2Results posted
• A Study of Tocilizumab and Methotrexate in Combination or as Monotherapy in Treatment-Naïve Patients With Early Rheumatoid ArthritisCompletedNCT01034137Phase 3Results posted
• Safety and Preliminary Efficacy of MOR103 in Patients With Active Rheumatoid ArthritisCompletedNCT01023256Phase 1/2Results posted
• A Study of Tocilizumab With or Without Methotrexate in Patients With Rheumatoid Arthritis.CompletedNCT01010503Phase 4Results posted
• A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid ArthritisCompletedNCT01007435Phase 3Results posted
• Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA)CompletedNCT01004432Phase 3Results posted
• Efficacy, Pharmacokinetics, Safety, and Immunogenicity Study of Abatacept Administered Subcutaneously to Treat Rheumatoid Arthritis in Japanese PatientsCompletedNCT01001832Phase 2/3Results posted
• A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and an Inadequate Response to MethotrexateCompletedNCT01000610Phase 4Results posted
• A Study of Tocilizumab in Combination With Disease-Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Moderate to Severe Active Rheumatoid Arthritis With an Inadequate Response to DMARDsCompletedNCT00996606Phase 3Results posted
• A Study of Tocilizumab Added to DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to DMARDs.CompletedNCT00996203Phase 4Results posted
• Study of KB003 In Biologics-Inadequate Rheumatoid ArthritisTerminatedNCT00995449Phase 2Results posted
• Assessing the Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis on the Antibody Response When Receiving Influenza Virus and Pneumococcal VaccinesCompletedNCT00993668Phase 4Results posted
• A Study of CDP870 as Add-on Meditation to Methotrexate (MTX) in Patients With Rheumatoid ArthritisCompletedNCT00993317Phase 3Results posted
• Substudy - Low Dose of Abatacept in Subjects With Rheumatoid ArthritisCompletedNCT00989235Phase 3Results posted
• Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug TreatmentCompletedNCT00984815Phase 3Results posted
• TORPEDO Study: A Study on Rapid Effect of Tocilizumab in Patients With Rheumatoid Arthritis With an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARDs) or Anti-TNFCompletedNCT00977106Phase 3Results posted
• A Study To Evaluate The Mechanism Of Action Of CP-690,550 In Patients With Rheumatoid ArthritisCompletedNCT00976599Phase 2Results posted
• Subcutaneous Golimumab (GLM) Plus DMARDs for Rheumatoid Arthritis, Followed by Intravenous/Subcutaneous GLM Strategy (P06129 AM2)CompletedNCT00975130Phase 3Results posted
• An Effectiveness and Safety Study of Intravenous Golimumab in Patients With Active Rheumatoid Arthritis Despite Treatment With Methotrexate TherapyCompletedNCT00973479Phase 3Results posted
• Intra-articular Glucocorticoid Treatment of the ElbowCompletedNCT00972530Not applicableResults posted
• A Study in Patients With Rheumatoid ArthritisCompletedNCT00966875Phase 2Results posted
• A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Combination Therapy of T-614 and Methotrexate in Rheumatoid Arthritis Patients With an Inadequate Response to MethotrexateCompletedNCT00965757Phase 3Results posted
• Study of CP-690,550 Versus Placebo In Rheumatoid Arthritis Patients On Background Methotrexate With Inadequate Response To Tumor Necrosis Factor (TNF) InhibitorsCompletedNCT00960440Phase 3Results posted
• A Study of Tocilizumab + DMARDs in Patients With Moderate to Severe Active Rheumatoid ArthritisCompletedNCT00951275Phase 3Results posted
• Brodalumab (AMG 827) in Rheumatoid Arthritis (RA) Participants With Inadequate Response to MethotrexateCompletedNCT00950989Phase 2Results posted
• Sleep and Immunity in Rheumatoid Arthritis : Remicade SubstudyCompletedNCT00948610Not applicableResults posted
• A Study Of PF-04171327 In The Treatment Of The Signs And Symptoms Of Rheumatoid ArthritisCompletedNCT00938587Phase 2Results posted
• A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to MethotrexateCompletedNCT00934648Phase 4Results posted
• Abatacept Versus Adalimumab Head-to-HeadCompletedNCT00929864Phase 3Results posted
• Retrospective Evaluation of the Radiographic Efficacy of Conventional and Biologic TreatmentCompletedNCT00929357Results posted
• Efficacy, Safety and Tolerability of AIN457 in Patients With Rheumatoid Arthritis (RA) Taking Methotrexate (MTX)CompletedNCT00928512Phase 2Results posted
• First-in-man Trial of NNC0142-0002 in Patients With Rheumatoid ArthritisCompletedNCT00927927Phase 1Results posted
• Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid ArthritisCompletedNCT00913458Phase 4Results posted
• Study of LX3305 in Subjects With Active Rheumatoid Arthritis on Stable MethotrexateCompletedNCT00903383Phase 2Results posted
• INCB028050 Compared to Background Therapy in Patients With Active Rheumatoid Arthritis (RA) With Inadequate Response to Disease Modifying Anti-Rheumatic DrugsCompletedNCT00902486Phase 2Results posted
• An Efficacy and Safety Study of Infliximab in Participants With Rheumatoid ArthritisCompletedNCT00896168Phase 4Results posted
• A Study Of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic Disease-modifying Antirheumatic Drugs (DMARDs)CompletedNCT00891020Phase 3Results posted
• A Study Comparing Infusion Rates of Tocilizumab in Patients With Moderate to Severe Rheumatoid ArthritisCompletedNCT00887341Phase 2Results posted
• Study To Evaluate The Safety And Efficacy Of ILV-094 In Subjects With Rheumatoid ArthritisCompletedNCT00883896Phase 2Results posted
• An Extension to Study MA21573, Evaluating Tocilizumab in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biological DMARDs and/or Anti-tumor Necrosis Factor (TNF) TherapyCompletedNCT00883753Phase 3Results posted
• A Study of Adalimumab in Japanese Subjects With Rheumatoid ArthritisCompletedNCT00870467Phase 3Results posted
• Living Well With Rheumatoid ArthritisCompletedNCT00869349Not applicableResults posted
• Study Comparing The Effect On Disease Activity When Reducing Or Discontinuing Etanercept In Subjects With RACompletedNCT00858780Phase 4Results posted
• A Study Comparing 2 Doses Of CP-690,550 Vs. Placebo For The Treatment Of Rheumatoid Arthritis In Patients On Other Background Arthritis MedicationsCompletedNCT00856544Phase 3Results posted
• A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid ArthritisCompletedNCT00853385Phase 3Results posted
• Long-term Treatment Study of Certolizumab Pegol (CDP870) as Add-on Medication to Methotrexate in Japanese Rheumatoid Arthritis (RA) PatientsCompletedNCT00851318Phase 3Results posted
• Long-term Treatment Study of Certolizumab Pegol Without Coadministration of Methotrexate in Japanese Rheumatoid Arthritis (RA) PatientsCompletedNCT00850343Phase 3Results posted
• Open-Label Study Comparing Etanercept to Conventional Disease Modifying Antirheumatic Drug (DMARD) TherapyCompletedNCT00848354Phase 4Results posted
• A Study to Assess the Effect of Tocilizumab on Signs and Symptoms in Patients With Rheumatoid ArthritisCompletedNCT00848120Phase 3Results posted
• Study of LX3305 and Methotrexate in Subjects With Stable Rheumatoid ArthritisCompletedNCT00847886Phase 1Results posted
• A 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background MethotrexateCompletedNCT00847613Phase 3Results posted
• A Study of Combination Treatment With MabThera (Rituximab) and RoActemra (Tocilizumab) Versus RoActemra in Patients With Rheumatoid Arthritis With an Incomplete Response to MethotrexateTerminatedNCT00845832Phase 2Results posted
• Cardiovascular Risk Markers in Patients With Rheumatoid Arthritis: Effect of Rituximab TherapyCompletedNCT00844714Not applicableResults posted
• Follow-up of Rheumatoid Arthritis (RA) Moderate to Low Disease Activity StudyCompletedNCT00843778Phase 3Results posted
• Phase I Study Of The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Intravenously Administered Doses Of PF-04236921 In Patients With Rheumatoid ArthritisCompletedNCT00838565Phase 1Results posted
• An Open Label Extension Study in Participants With Rheumatoid ArthritisCompletedNCT00837811Phase 2Results posted
• Anti-TNF Agents for the Treatment of Rheumatoid ArthritisCompletedNCT00837434Phase 4Results posted
• A Phase 3 Study Comparing 2 Doses of CP-690,550 vs. Placebo for Treatment of Rheumatoid ArthritisCompletedNCT00814307Phase 3Results posted
• A Study of Tocilizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Current Non-Biologic DMARDsCompletedNCT00810277Phase 3Results posted
• A Study of Tocilizumab and Methotrexate Treatment Strategies (Adding Tocilizumab to Methotrexate Versus Switching to Tocilizumab) in Patients With Active Rheumatoid Arthritis With Inadequate Response to Prior Methotrexate TreatmentCompletedNCT00810199Phase 3Results posted
• A Pilot Study of the Feasibility of Discontinuation of Adalimumab in Stable Rheumatoid Arthritis Patients in Clinical RemissionCompletedNCT00808509Phase 4Results posted
• A Study to Evaluate Ocrelizumab in Combination With Methotrexate Compared With Infliximab Plus Methotrexate in Patients With Active Rheumatoid Arthritis Currently Responding Inadequately to Etanercept or AdalimumabTerminatedNCT00808210Phase 2Results posted
• Open-Label, Multicenter Extension Study for Patients Completing Treatment Phase of a Rigel-Sponsored R935788 StudiesTerminatedNCT00805467Phase 2Results posted
• Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA)TerminatedNCT00796705Phase 4Results posted
• Drug Outcome Survey for Biological Treatments in Rheumatoid Arthritis: an Observational Study (Dose)CompletedNCT00794118Results posted
• Current Adoption of Composite Indices in Evaluating Rheumatoid Arthritis Patients: An Observational StudyCompletedNCT00793403Results posted
• Efficacy Confirmation Trial of CDP870 as add-on Medication to Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA)CompletedNCT00791999Phase 2/3Results posted

← Arthritis, Rheumatoid overview